Many women are familiar with the brand name BOTOX® Cosmetic (onabotulinumtoxinA), but a new study from SheSpeaks™, an online community of women, reveals what they really want to know about it.1 To address the most common questions women have – and there are nearly 10 million women who are considering treatment2 – Allergan Inc., maker of BOTOX® Cosmetic, teamed up with SheSpeaks to identify these questions and provide answers.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7334951-allergan-shespeaks-survey-reveals-what-u-s-women-really-want-to-know-about-botox-cosmetic/
The legalization of marijuana in many states may be changing the way teens think about marijuana and other harmful substances like heroin. A new study commissioned by Rosecrance shows that the legalization of marijuana may encourage teenagers to experiment with the drug, along with other substances.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7219651-rosecrance-study-teenagers-believe-marijuana-legalization-may-encourage-drug-substance-experimentation/
Chiasma, Inc., a U.S. privately–held biopharma company developing octreotide capsules for the orphan condition acromegaly, today announced two new studies presented at the 97th Endocrine Society (ENDO) Annual Meeting in San Diego, Calif. The studies provide additional data from Chiasma’s Phase III trial and new findings on the patient burden of current injection therapies.
“We now have data to help clinicians determine whether octreotide capsules, if approved, are likely to help their patient with acromegaly maintain response,” said Shlomo Melmed, M.D., senior vice president and dean, Cedars–Sinai Medical Center, Los Angeles and global study principal investigator. “Furthermore, the Phase III results show the safety and efficacy of octreotide capsules can be reliably determined within 12 weeks of initiating therapy.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7436451-endo-chiasma-clinical-data/
Popular tradition gives vinegar many healthful benefits, both through topical and internal use: it is antiseptic, antioxidant, purifying, soothing, protective, and toning.
This new interest motivated hair colouring pioneer Christophe Robin to study the cosmetic properties linked to vinegar, and research formulas inspired by traditional recipes to create a product that meets the current needs of both men and women.
To view the Multimedia News Release, go to http://www.multivu.com/players/uk/7560651-christophe-robins-botanical-vinegars/
Mobile Printer is free and available for students of centennial college. This community college(Centennial College) bring some more technologies in students' study life.
When the mid-afternoon rolls around, many of us wouldn’t mind curling up in bed and taking a nap. In fact, a recent study conducted by GfK’s KnowledgePanel® found that one-third of Americans say they feel drowsy, less productive and worn out several times a week, at an average of 2:58 pm.
This afternoon crash can be improved with the help of a healthy snack like almonds. Together, California Almonds and actress Anna Camp have partnered to ensure Americans can “Carpe PM” – or “seize the afternoon” -- and crunch their crash.
To view the multimedia release go to:
https://www.multivu.com/players/English/8118051-california-almonds-anna-camp-carpe-pm/
Kohler raises the bar on toilet flushing platforms with the launch of its new Revolution 360 swirl flush technology. The brands extensive experience in the toilet industry supports its understanding that critical drivers of owner satisfaction are toilet cleanliness and flush performance – both addressed in the new platform.
Revolution 360 is Kohler’s most complete flush ever developed and is powered by the brand’s widely popular AquaPiston canister technology which allows water to flow out of the tank at 360 degrees, increasing the power and effectiveness of the flush. Once out of the tank the water flows into the bowl from a single, powerful port and swirls throughout the bowl. Utilizing this swirling motion, Revolution 360 keeps the bowl cleaner, longer than a conventional flush. Kohler’s team of engineers engaged experiment and Computational Fluid Dynamics methods to study, improve and perfect even the smallest details to ensure complete rinsing of the entire bowl surface.
To view the multimedia release go to:
https://www.multivu.com/players/English/8176751-kohler-revolution-360-toilet-flushing-platform/
WebMD and Scripps Translational Science Institute (STSI) today announced a new investigative study designed to improve researchers’ and health care professionals’ understanding of what contributes to healthy pregnancies and positive pregnancy outcomes. The Healthy Pregnancy Study will use WebMD’s newly redesigned and enhanced Pregnancy app for iPhone. Incorporation of the Apple ResearchKit software framework will enable survey participants to eConsent, easily and anonymously answer questions, and share connected device data about their pregnancies with researchers for analysis.
“Pregnant women are one of the least studied populations in medical research,” said Dr. Eric Topol, director of STSI and editor-in-chief of Medscape. “The results of our Healthy Pregnancy Study -- on the foundation of an exceptionally popular smartphone app -- will ultimately provide expectant mothers, researchers, and health care professionals with new medical insights to avoid complications during pregnancy.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7579757-webmd-stsi-healthy-pregnancy-study-app/
The Smithsonian’s Lemelson Center for the Study of Invention and Innovation will open its first permanent public home—the Lemelson Hall of Invention and Innovation—at the National Museum of American History July 1. The Hall will feature “Places of Invention,” a signature 3,500 square-foot exhibition examining hotspots of invention throughout history; Draper Spark!Lab, a hands-on space for children aged 6 to 12; and “Inventive Minds,” a small gallery that will introduce the work of the Lemelson Center.
To view the Multimedia News Release, go http://www.multivu.com/players/English/7552051-smithsonian-lemelson-hall-invention-innovation/
Se pone en marcha el primer estudio integral a largo plazo que compara diferentes medicaciones para el tratamiento de la diabetes tipo 2 a escala nacional. El estudio GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness - Estrategias para la reducción de la glucemia en la diabetes: una comparativa de la eficacia) comparará los efectos beneficiosos y riesgos a largo plazo de cuatro fármacos ampliamente utilizados en el tratamiento de la diabetes, en combinación con metformina, la medicación de primera línea más frecuente para tratar la diabetes tipo 2. El estudio GRADE está buscando voluntarios latinos.
Para ver el Multimedia News Release, vaya a http://www.multivu.com/mnr/65066-nih-grade-study-on-type-2-diabetes-medication-seeks-latino-volunteers
Positive strides have been made since 1995 to advance science literacy in the United States, but teachers and parents agree that more hands-on, experiential learning must be adopted in order to improve science education for future generations, according to the results of the 2015 Bayer Facts of Science Education Survey released today.
For 20 years, Bayer has issued the survey, which assesses science education in the United States and evaluates its development. Although positive strides have been made, survey results emphasize the critical need to improve science education and literacy for future generations. Teachers, for example, universally agree (99 percent) that more hands-on experiential learning in general would benefit student learning.
In response, Bayer is announcing a five-year commitment to provide 1 million hands-on science learning experiences for children by 2020, timed to the 20th anniversary of the Making Science Make Sense® program, Bayer’s company-wide initiative that advances science literacy across the United States.
To view the multimedia release go to:
http://www.multivu.com/players/English/7452954-bayer-children-science-education/
